Johnson & Johnson Advised Coronavirus Simulation And Now Stands To Gain Financially With New Vaccine

This article was written by Spiro Skouras and originally published at Activist Post

Prior to the coronavirus outbreak, The Johns Hopkins Center for Health Security hosted Event 201, a high-level pandemic exercise focused on a coronavirus outbreak — yes they ran a simulation of exactly what we see unfolding right now, before it happened!

The pandemic exercise was conducted in partnership with the World Economic Forum and the Bill and Melinda Gates Foundation. During Event 201 Johnson & Johnson was asked specifically about a coronavirus vaccine.

When asked, the Johnson & Johnson representative talked about the need for regulatory flexibility for an accelerated vaccine, financing and business. Not once did he mention safety or effectiveness. In today’s news, we see that Johnson & Johnson are currently working on a vaccine and they’re “pretty confident” they can quickly develop one.